|
July. 05, 2024 |
|
|
Mar. 04, 2026 |
|
|
jRCT1011240022 |
An exploratory iNvestigation of rEal-World pharmacokinetics and TherApeutic drug monitoring-Guided personalized dosing of novel molEcular Targeted drugs (NEWTARGET study) |
|
An exploratory iNvestigation of rEal-World pharmacokinetics and TherApeutic drug monitoring-Guided personalized dosing of novel molEcular Targeted drugs (NEWTARGET study) |
Masahide Fukudo |
||
Sapporo Medical University Hospital |
||
South-1, West-16, Chuo-ku, Sapporo, Hokkaido |
||
+81-11-688-9686 |
||
fukudom@sapmed.ac.jp |
||
Masahide Fukudo |
||
Sapporo Medical University Hospital |
||
South-1, West-16, Chuo-ku, Sapporo, Hokkaido |
||
+81-11-688-9686 |
||
fukudom@sapmed.ac.jp |
Recruiting |
July. 05, 2024 |
||
| 50 | ||
Observational |
||
Subjects whose medical care and prognostic information can be obtained from medical records |
||
Subjects presenting with any of the following will be excluded from the study: |
||
| No limit | ||
| No limit | ||
Both |
||
Neoplasms (Lung Cancer etc.), Inflammatory Bowel Diseases, Rheumatoid Arthritis, Autoimmune Diseases |
||
D009369, D015212, D001172, D001327 |
||
The variability of pharmacokinetics |
||
-Pharmacokinetic linearity across doses administered |
||
| Sapporo Medical University Hospital |
| Institutional Review Board of Sapporo Medical University Hospital | |
| South-1, West-16, Chuo-ku, Sapporo, Hokkaido, Hokkaido | |
+81-11-611-2111 |
|
| ji-rskk@sapmed.ac.jp | |
| Approval | |
June. 27, 2024 |
No |
none |